Andecaliximab With mFOLFOX6 as First Line Treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Leucovorin
Related studies linked through entity extraction aliases.
A Study of FOLFOXIRI Plus Cetuximab vs. FOLFOXIRI Plus Bevacizumab
- Status
- UNKNOWN
- Phase
- PHASE2
Perioperative Chemotherapy Compared To Neoadjuvant Chemoradiation in Patients With Adenocarcinoma of the Esophagus
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Comparison the Effects of Different Neoadjuvant Chemotherapy Regimen on Acute Toxicity, Tumor Response, and Survival in Patients With Advanced Nasopharyngeal Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE3
A Phase Ib Study of Humanized Anti-VEGF Monoclonal Antibody (Sevacizumab) Injection Plus FOLFIRI in Chinese Patients With Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
HAIC Using Oxaliplatin Plus Fluorouracil/Leucovorin for Patients With Locally Advanced HCC
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Ruxolitinib Phosphate or Dasatinib With Chemotherapy in Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
DC-CIK Immunotherapy Plus Chemotherapy vs Chemotherapy Alone in the Adjuvant Treatment of Stage III Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Study to Compare CAPTEM vs FOLFIRI as Second Line Treatment in Advanced, Colorectal Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Study of 2-weekly RAILIRI Versus FOLFIRI as Second-line Treatment in Advanced Colorectal Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Induction FOLFOX With or Without Aflibercept Followed by Chemoradiation in High Risk Locally Advanced Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Personalized Therapy for Esophagogastric Cancer Using Thymidylate Synthase Genetic Markers
- Status
- WITHDRAWN
- Phase
- PHASE2
Escalated Dose of Irinotecan in mCRC
- Status
- COMPLETED
- Phase
- NA
A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Genotype-Directed Study Of Irinotecan Dosing In FOLFIRI + BevacizumabTreated Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Prexasertib (LY2606368) With Chemotherapy or Targeted Agents in Participants With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Inoperable Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Operable Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Phase II Study of Zaltrap and Chemotherapy for Advanced Resectable Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Advanced Gastrointestinal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2